Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Medical Industry Today.
Press releases published on April 3, 2025
Crescent Biopharma Appoints Joshua Brumm as Chief Executive Officer and Expands Leadership Team to Advance Pipeline of Potentially Best-in-Class Oncology Therapeutics
GlobeNewswire
·
April 3, 2025
Jonathan McNeill, M.D., Appointed President and Chief Operating Officer Ellie Im, M.D., Appointed Chief Medical Officer Additional Leadership Appointments: Rick Scalzo, MBA, as Chief Financial Officer, and Amy Reilly, as Chief Communications Officer Team …
Aveanna Healthcare Holdings Announces Agreement to Acquire Thrive Skilled Pediatric Care
GlobeNewswire
·
April 3, 2025
ATLANTA, April 03, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced that it has entered into …
Intellia Therapeutics Announces First Patient Dosed in the MAGNITUDE-2 Phase 3 Study of Nexiguran Ziclumeran (nex-z), a One-Time Gene Editing-Based Treatment for Transthyretin (ATTR) Amyloidosis with Polyneuropathy
GlobeNewswire
·
April 3, 2025
CAMBRIDGE, Mass., April 03, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced the first patient has been dosed …
Minovia Therapeutics Announces FDA Clearance of Second IND Application, for a Phase II Clinical Trial of Lead Product MNV-201 in Pearson Syndrome
GlobeNewswire
·
April 3, 2025
MNV-201 is Minovia’s second generation mitochondrial cell therapy product composed of autologous hematopoietic stem cells enriched with allogeneic mitochondria Rare Pediatric Designation granted MNV-201 is also being studied in a Phase Ib for low-risk …
MoonLake Secures up to $500 Million in Non-Dilutive Financing from Hercules Capital and Announces a Capital Markets Update on April 29 to Provide Important Clinical Updates
GlobeNewswire
·
April 3, 2025
Agreement with Hercules Capital significantly increases financial and operational strength, provides up to $500 million in capital with no dilution to shareholders, an attractive cost of capital and low operational and strategic incumbrances, and sets a …
Boundless Bio to Participate in the Needham Virtual Healthcare Conference
GlobeNewswire
·
April 3, 2025
SAN DIEGO, April 03, 2025 (GLOBE NEWSWIRE) -- Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified …
Publication of Data from Prospective, Multicenter Study Demonstrates Positive Survival Outcomes in Patients with Low-Risk Melanoma Who Avoided Sentinel Lymph Node Biopsy with Information from Castle Biosciences’ DecisionDx®-Melanoma Test
GlobeNewswire
·
April 3, 2025
Consistent with prior studies, published results from Castle’s DECIDE study show DecisionDx-Melanoma can both accurately identify patients with less than 5% risk of sentinel lymph node (SLN) positivity, who can safely consider forgoing the sentinel lymph …
Auron Presents New Preclinical Data for AUTX-703 in Small Cell Lung Cancer (SCLC)
GlobeNewswire
·
April 3, 2025
NEWTON, Mass., April 03, 2025 (GLOBE NEWSWIRE) -- Auron Therapeutics, a clinical-stage biotechnology company targeting cell-state plasticity to improve patient outcomes in oncology and inflammatory disease, today announced data from a poster presentation …
Ligandrol (LGD-4033) SARMs: Ligandrol Benefits, Ligandrol Results & Buy Ligandrol Pills Alternatives Ligan 4033 By CrazyBulk
GlobeNewswire
·
April 3, 2025
NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- “We’ve got several pro bodybuilding athletes ready and waiting to get to know you in our free private CrazyBulk community. And you’ll receive an invite to it the minute you purchase any CrazyBulk product. These …
Sai Life Sciences sets up Peptide Research Center in India
GlobeNewswire
·
April 3, 2025
HYDERABAD, India, April 03, 2025 (GLOBE NEWSWIRE) -- Sai Life Sciences Limited (BSE: 544306 I NSE: SAILIFE), an innovator-focused Contract Research, Development, and Manufacturing Organization (CRDMO), has inaugurated a dedicated Peptide Research Center at …
Arialief: We Tested It—Here’s Our Honest Arialief Review “Shocking Conclusion”
GlobeNewswire
·
April 3, 2025
AURORA, Colo., April 03, 2025 (GLOBE NEWSWIRE) -- Arialief caught my attention from the very first day I heard about it. It’s not every day I commit to testing a new supplement for over three months and then share my personal journey. As someone who has …
Prime Biome: We Tested It—Here’s My Honest Prime Biome Review After 117 Days!
GlobeNewswire
·
April 3, 2025
ST. PETERSBURG, Fla., April 03, 2025 (GLOBE NEWSWIRE) -- Prime Biome caught my attention the very first day I heard about it. It’s not every day that I commit to a new supplement for nearly four months and then share my entire journey. But after …
Boehringer Ingelheim strengthens antibody-drug conjugate portfolio with new NBE Therapeutics R&D center in Basel
GlobeNewswire
·
April 3, 2025
CHF 27 million investment significantly bolsters Boehringer's ADC portfolio, driven by its subsidiary, NBE Therapeutics, to achieve the company’s aim of transforming the lives of people with cancer. Basel, Switzerland, Thursday, 03.04.2025 – Today NBE …
Vítej, budoucnosti. Endoskopický systém ELUXEO® 8000
GlobeNewswire
·
April 3, 2025
RATINGEN, Německo, April 03, 2025 (GLOBE NEWSWIRE) -- Tým FUJIFILM Healthcare Europe s potěšením oznamuje evropské uvedení svého pokročilého endoskopického systému ELUXEO® 8000* s novými terapeutickými možnostmi, řízením pracovních postupů a lepší kvalitou …
Welcome, Future. ELUXEO® 8000-Endoskopiesystem
GlobeNewswire
·
April 3, 2025
RATINGEN, Deutschland, April 03, 2025 (GLOBE NEWSWIRE) -- Das Team von FUJIFILM Healthcare Europe freut sich, die Markteinführung von ELUXEO® 8000* in Europa bekannt zu geben, unserem neuen fortschrittlichen Endoskopiesystem mit neuen therapeutischen …
Welcome, Future. Sistema endoscopico ELUXEO® 8000
GlobeNewswire
·
April 3, 2025
RATINGEN, Germania, April 03, 2025 (GLOBE NEWSWIRE) -- Il team FUJIFILM Healthcare Europe è entusiasta di annunciare l’uscita in Europa di ELUXEO® 8000*, il nostro nuovo sistema endoscopico avanzato che include nuove capacità terapeutiche, gestione del …
Welcome, Future (Bem-vindo, futuro). Sistema de endoscopia ELUXEO® 8000
GlobeNewswire
·
April 3, 2025
RATINGEN, Alemanha, April 03, 2025 (GLOBE NEWSWIRE) -- A equipa da FUJIFILM Healthcare Europe tem o prazer de anunciar o lançamento na Europa do ELUXEO® 8000*, o novo sistema de endoscopia avançada com novas capacidades terapêuticas, gestão do fluxo de …
Welcome, Future (Bienvenido, futuro). Sistema de endoscopia ELUXEO® 8000
GlobeNewswire
·
April 3, 2025
RATINGEN, Alemania, April 03, 2025 (GLOBE NEWSWIRE) -- Al equipo de FUJIFILM Healthcare Europe nos complace anunciar el lanzamiento de ELUXEO 8000, nuestro nuevo sistema de endoscopia avanzado con nuevas capacidades terapéuticas, gestión del flujo de …
LIfT BioSciences gains access to half a million allogeneic donors through collaboration with Gift of Life Biologics
GlobeNewswire
·
April 3, 2025
Press release LIfT BioSciences gains access to half a million allogeneic donors through collaboration with Gift of Life Biologics Access to extensive donor pool supports LIfT’s move into the clinic London, 03 April 2025 – LIfT BioSciences, (‘LIfT’ or ‘the …
Welcome, Future. ELUXEO® 8000 Endoscopy System
GlobeNewswire
·
April 3, 2025
RATINGEN, Germany, April 03, 2025 (GLOBE NEWSWIRE) -- The FUJIFILM Healthcare Europe Team are excited to announce the European launch of ELUXEO® 8000*, our new advanced endoscopy system with new therapeutic capabilities, workflow management and improved …